Ultrasound triggered, image guided, local drug delivery

Journal of Controlled Release

Volumn 148, Issue 1, 2010, Pages 25-33

  Deckers, Roel ^a   Moonen, Chrit T W ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UMR 5287   (France)

Author keywords

Cavitation; Image guided drug delivery; Microbubbles; Temperature sensitive liposomes; Ultrasound

Indexed keywords

BIO-EFFECTS; BIODISTRIBUTIONS; CAVITATION EFFECT; DIFFUSIVITIES; DRUG RELEASE; HUMAN BODIES; IMAGE GUIDANCES; IMAGE-GUIDED; LOCAL DRUG DELIVERY; MECHANICAL ENERGIES; MECHANICAL FORCE; MICROBUBBLES; NANOCARRIERS; NON-INVASIVE WAY; PHARMACOKINETICS AND PHARMACODYNAMICS; RADIATION FORCES; REALTIME IMAGING; SPATIO-TEMPORAL; TARGET IDENTIFICATION; TEMPERATURE-SENSITIVE LIPOSOMES; THERAPEUTIC EFFICACY; THERMO SENSITIVE; TISSUE HEATING; ULTRASOUND; ULTRASOUND IMAGING; ULTRASOUND PRESSURE;

CAVITATION; DRUG DELIVERY; DRUG PRODUCTS; IMAGE PROCESSING; LIPOSOMES; MAGNETIC RESONANCE; PHOSPHOLIPIDS; PHYSIOLOGICAL MODELS; RADIATION EFFECTS;

ULTRASONICS;

CARBON 11; CISPLATIN; FLUORINE 18; FLUOROURACIL; LIPOSOME; NITROGEN 13; TEMOZOLOMIDE;

ARTICLE; BIOLUMINESCENCE; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLUORESCENCE IMAGING; HEAT SENSITIVITY; MICROBUBBLE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCANNING ELECTROCHEMICAL MICROSCOPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ULTRASOUND;

DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HOT TEMPERATURE; MAGNETIC RESONANCE IMAGING; PERMEABILITY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; ULTRASONICS;

EID: 78649529320     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.07.117     Document Type: Article

References (117)

1. Bao S., Thrall B.D., Miller D.L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 1997, 23:953-959.
2. Greenleaf W.J., Bolander M.E., Sarkar G., Goldring M.B., Greenleaf J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med. Biol. 1998, 24:587-595.
3. Lawrie A., Brisken A.F., Francis S.E., Tayler D.I., Chamberlain J., Crossman D.C., Cumberland D.C., Newman C.M. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 1999, 99:2617-2620.
4. Price R.J., Skyba D.M., Kaul S., Skalak T.C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998, 98:1264-1267.
5. Song J., Chappell J.C., Qi M., VanGieson E.J., Kaul S., Price R.J. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J. Am. Coll. Cardiol. 2002, 39:726-731.
6. Solbiati L., Ierace T., Goldberg S.N., Sironi S., Livraghi T., Fiocca R., Servadio G., Rizzatto G., Mueller P.R., Del Maschio A., Gazelle G.S. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997, 202:195-203.
7. Nolsoe C.P., Torp-Pedersen S., Burcharth F., Horn T., Pedersen S., Christensen N.E., Olldag E.S., Andersen P.H., Karstrup S., Lorentzen T., et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology 1993, 187:333-337.
8. Braun J., Bollow M., Seyrekbasan F., Haberle H.J., Eggens U., Mertz A., Distler A., Sieper J. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. J. Rheumatol. 1996, 23:659-664.
9. Rasmus M., Huegli R.W., Bilecen D., Jacob A.L. Robotically assisted CT-based procedures. Minim. Invasive Ther. Allied Technol. 2007, 16:212-216.
10. Hindley J., Gedroyc W.M., Regan L., Stewart E., Tempany C., Hynyen K., McDannold N., Inbar Y., Itzchak Y., Rabinovici J., Kim H.S., Geschwind J.F., Hesley G., Gostout B., Ehrenstein T., Hengst S., Sklair-Levy M., Shushan A., Jolesz F. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am. J. Roentgenol. 2004, 183:1713-1719.
11. Tempany C.M., Stewart E.A., McDannold N., Quade B.J., Jolesz F.A., Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003, 226:897-905.
12. Jain R.K. Delivery of molecular medicine to solid tumors. Science 1996, 271:1079-1080.
13. Jain R.K. The next frontier of molecular medicine: delivery of therapeutics. Nat. Med. 1998, 4:655-657.
14. Berk D.A., Yuan F., Leunig M., Jain R.K. Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc. Natl Acad. Sci. USA 1997, 94:1785-1790.
15. Juweid M., Neumann R., Paik C., Perez-Bacete M.J., Sato J., van Osdol W., Weinstein J.N. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res. 1992, 52:5144-5153.
16. Besic E. Physical mechanisms and methods employed in drug delivery to tumors. Acta Pharm. 2007, 57:249-268.
17. Dalecki D. Mechanical bioeffects of ultrasound. Annu. Rev. Biomed. Eng. 2004, 6:229-248.
18. Miller M.W., Miller D.L., Brayman A.A. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med. Biol. 1996, 22:1131-1154.
19. Fry W.J., Wulff V.J., Tucker D., Fry F.J. Physical factors involved in ultrasonically induced changes in living systems: I. Identification of non-temperature effects. J. Acoust. Soc. Am. 1950, 22:867-876.
20. Karino T., Koga S., Maeta M. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn J. Surg. 1988, 18:276-283.
21. Lefor A.T., Makohon S., Ackerman N.B. The effects of hyperthermia on vascular permeability in experimental liver metastasis. J. Surg. Oncol. 1985, 28:297-300.
22. Gaber M.H., Wu N.Z., Hong K., Huang S.K., Dewhirst M.W., Papahadjopoulos D. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36:1177-1187.
23. Kong G., Braun R.D., Dewhirst M.W. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 2000, 60:4440-4445.
24. Kong G., Braun R.D., Dewhirst M.W. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res. 2001, 61:3027-3032.
25. Dreher M.R., Liu W., Michelich C.R., Dewhirst M.W., Yuan F., Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J. Natl Cancer Inst. 2006, 98:335-344.
26. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., Jain R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995, 55:3752-3756.
27. Drummond D.C., Noble C.O., Hayes M.E., Park J.W., Kirpotin D.B. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J. Pharm. Sci. 2008, 97:4696-4740.
28. Koning G.A., Eggermont A.M., Lindner L.H., Ten Hagen T.L. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm. Res. 2010, 143:274-279.
29. Safra T., Muggia F., Jeffers S., Tsao-Wei D.D., Groshen S., Lyass O., Henderson R., Berry G., Gabizon A. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500mg/m2. Ann. Oncol. 2000, 11:1029-1033.
30. Waterhouse D.N., Tardi P.G., Mayer L.D., Bally M.B. A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles. Drug Saf. 2001, 24:903-920.
31. Yatvin M.B., Weinstein J.N., Dennis W.H., Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978, 202:1290-1293.
32. Lindner L.H., Eichhorn M.E., Eibl H., Teichert N., Schmitt-Sody M., Issels R.D., Dellian M. Novel temperature-sensitive liposomes with prolonged circulation time. Clin. Cancer Res. 2004, 10:2168-2178.
33. Needham D., Dewhirst M.W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv. Drug Deliv. Rev. 2001, 53:285-305.
34. Apfel R.E. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br. J. Cancer Suppl. 1982, 140-146.
35. T.G. Leighton, The acoustic bubble, London: Academic ed., 1994.
36. Deckers R., Rome C., Moonen C.T. The role of ultrasound and magnetic resonance in local drug delivery. J. Magn. Reson. Imaging 2008, 27:400-409.
37. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv. Drug Deliv. Rev. 2008, 60:1193-1208.
38. Klibanov A.L. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest. Radiol. 2006, 41:354-362.
39. Larkin J.O., Casey G.D., Tangney M., Cashman J., Collins C.G., Soden D.M., O'Sullivan G.C. Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin. Ultrasound Med. Biol. 2008, 34:406-413.
40. Nelson J.L., Roeder B.L., Carmen J.C., Roloff F., Pitt W.G. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res. 2002, 62:7280-7283.
41. Schroeder A., Honen R., Turjeman K., Gabizon A., Kost J., Barenholz Y. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J. Control. Release 2009, 137:63-68.
42. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Control. Release 2009, 138:268-276.
43. Tartis M.S., McCallan J., Lum A.F., LaBell R., Stieger S.M., Matsunaga T.O., Ferrara K.W. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med. Biol. 2006, 32:1771-1780.
44. Unger E.C., McCreery T.P., Sweitzer R.H., Caldwell V.E., Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest. Radiol. 1998, 33:886-892.
45. Taniyama Y., Tachibana K., Hiraoka K., Namba T., Yamasaki K., Hashiya N., Aoki M., Ogihara T., Yasufumi K., Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002, 105:1233-1239.
46. Kinoshita M., Hynynen K. A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem. Biophys. Res. Commun. 2005, 335:393-399.
47. Saito M., Mazda O., Takahashi K.A., Arai Y., Kishida T., Shin-Ya M., Inoue A., Tonomura H., Sakao K., Morihara T., Imanishi J., Kawata M., Kubo T. Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J. Orthop. Res. 2007, 25:1308-1316.
48. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001, 220:640-646.
49. McDannold N., Vykhodtseva N., Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol. 2006, 51:793-807.
50. Treat L.H., McDannold N., Vykhodtseva N., Zhang Y., Tam K., Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int. J. Cancer 2007, 121:901-907.
51. Kudo N., Okada K., Yamamoto K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys. J. 2009, 96:4866-4876.
52. Schlicher R.K., Radhakrishna H., Tolentino T.P., Apkarian R.P., Zarnitsyn V., Prausnitz M.R. Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med. Biol. 2006, 32:915-924.
53. van Wamel A., Kooiman K., Harteveld M., Emmer M., ten Cate F.J., Versluis M., de Jong N. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J. Control. Release 2006, 112:149-155.
54. Yudina A., Lepetit-Coiffe M., Moonen C.T. Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement. Mol. Imaging Biol. 2010.
55. Hallow D.M., Mahajan A.D., Prausnitz M.R. Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J. Control. Release 2007, 118:285-293.
56. Meijering B.D., Juffermans L.J., van Wamel A., Henning R.H., Zuhorn I.S., Emmer M., Versteilen A.M., Paulus W.J., van Gilst W.H., Kooiman K., de Jong N., Musters R.J., Deelman L.E., Kamp O. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ. Res. 2009, 104:679-687.
57. Tran T.A., Le Guennec J.Y., Bougnoux P., Tranquart F., Bouakaz A. Characterization of cell membrane response to ultrasound activated microbubbles. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2008, 55:43-49.
58. Tran T.A., Roger S., Le Guennec J.Y., Tranquart F., Bouakaz A. Effect of ultrasound-activated microbubbles on the cell electrophysiological properties. Ultrasound Med. Biol. 2007, 33:158-163.
59. Duvshani-Eshet M., Adam D., Machluf M. The effects of albumin-coated microbubbles in DNA delivery mediated by therapeutic ultrasound. J. Control. Release 2006, 112:156-166.
60. Walton C.B., Shohet R.V. Tiny bubbles and endocytosis?. Circ. Res. 2009, 104:563-565.
61. Marmottant P., Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003, 423:153-156.
62. Crowder K.C., Hughes M.S., Marsh J.N., Barbieri A.M., Fuhrhop R.W., Lanza G.M., Wickline S.A. Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery. Ultrasound Med. Biol. 2005, 31:1693-1700.
63. O'Brien W.D. Ultrasound-biophysics mechanisms. Prog. Biophys. Mol. Biol. 2007, 93:212-255.
64. Mesiwala A.H., Farrell L., Wenzel H.J., Silbergeld D.L., Crum L.A., Winn H.R., Mourad P.D. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med. Biol. 2002, 28:389-400.
65. Seidl M., Steinbach P., Worle K., Hofstadter F. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics 1994, 32:397-400.
66. Frenkel V., Kimmel E., Iger Y. Ultrasound-facilitated transport of silver chloride (AgCl) particles in fish skin. J. Control. Release 2000, 68:251-261.
67. Frenkel V., Kimmel E., Iger Y. Ultrasound-induced intercellular space widening in fish epidermis. Ultrasound Med. Biol. 2000, 26:473-480.
68. Yuh E.L., Shulman S.G., Mehta S.A., Xie J., Chen L., Frenkel V., Bednarski M.D., Li K.C. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. Radiology 2005, 234:431-437.
69. Frenkel V., Etherington A., Greene M., Quijano J., Xie J., Hunter F., Dromi S., Li K.C. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad. Radiol. 2006, 13:469-479.
70. Dittmar K.M., Xie J., Hunter F., Trimble C., Bur M., Frenkel V., Li K.C. Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. Radiology 2005, 235:541-546.
71. O'Neill B.E., Vo H., Angstadt M., Li K.P., Quinn T., Frenkel V. Pulsed high intensity focused ultrasound mediated nanoparticle delivery: mechanisms and efficacy in murine muscle. Ultrasound Med. Biol. 2009, 35:416-424.
72. Hancock H.A., Smith L.H., Cuesta J., Durrani A.K., Angstadt M., Palmeri M.L., Kimmel E., Frenkel V. Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism. Ultrasound Med. Biol. 2009, 35:1722-1736.
73. O'Neill B.E., Frenkel V., Li K.C.P., Quinn T.P. Pulsed HIFU for enhanced drug delivery: a study of possible mechanisms. International Symposium on Therapeutic Ultrasound, Oxford, UK 2006.
74. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., Verweij J., Van Glabbeke M., van Oosterom A.T., Christian M.C., Gwyther S.G. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 2000, 92:205-216.
75. Motzer R.J., Rini B.I., Bukowski R.M., Curti B.D., George D.J., Hudes G.R., Redman B.G., Margolin K.A., Merchan J.R., Wilding G., Ginsberg M.S., Bacik J., Kim S.T., Baum C.M., Michaelson M.D. Sunitinib in patients with metastatic renal cell carcinoma. Jama 2006, 295:2516-2524.
76. Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., Silberman S., Capdeville R., Dimitrijevic S., Druker B., Demetri G.D. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 2001, 344:1052-1056.
77. Curran S.D., Muellner A.U., Schwartz L.H. Imaging response assessment in oncology. Cancer Imaging 2006, 6:S126-130.
78. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003, 17:545-580.
79. Ginos J.Z., Cooper A.J., Dhawan V., Lai J.C., Strother S.C., Alcock N., Rottenberg D.A. [13N]cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J. Nucl. Med. 1987, 28:1844-1852.
80. Meikle S.R., Matthews J.C., Brock C.S., Wells P., Harte R.J., Cunningham V.J., Jones T., Price P. Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study. Cancer Chemother. Pharmacol. 1998, 42:183-193.
81. Saleem A., Yap J., Osman S., Brady F., Suttle B., Lucas S.V., Jones T., Price P.M., Aboagye E.O. Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action. Lancet 2000, 355:2125-2131.
82. Aboagye E.O., Saleem A., Cunningham V.J., Osman S., Price P.M. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer. Cancer Res. 2001, 61:4937-4941.
83. Bao A., Goins B., Klipper R., Negrete G., Phillips W.T. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies. J. Pharmacol. Exp. Ther. 2004, 308:419-425.
84. Harrington K.J., Mohammadtaghi S., Uster P.S., Glass D., Peters A.M., Vile R.G., Stewart J.S. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 2001, 7:243-254.
85. Khaibullina A., Jang B.S., Sun H., Le N., Yu S., Frenkel V., Carrasquillo J.A., Pastan I., Li K.C., Paik C.H. Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J. Nucl. Med. 2008, 49:295-302.
86. Sorensen A.G. Magnetic resonance as a cancer imaging biomarker. J. Clin. Oncol. 2006, 24:3274-3281.
87. Tilcock C., Unger E., Cullis P., MacDougall P. Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 1989, 171:77-80.
88. Tilcock C., Ahkong Q.F., Koenig S.H., Brown R.D., Davis M., Kabalka G. The design of liposomal paramagnetic MR agents: effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates. Magn. Reson. Med. 1992, 27:44-51.
89. J.A. De Zwart, R. Salomir, F. Vimeux, J. Klaveness, C.T.W. Moonen, On the feasibility of local drug delivery using thermo-sensitive liposomes and MR-guided focused ultrasound, in: ISMRM, Denver, 2000, pp. 43.
90. Frich L., Bjornerud A., Fossheim S., Tillung T., Gladhaug I. Experimental application of thermosensitive paramagnetic liposomes for monitoring magnetic resonance imaging guided thermal ablation. Magn. Reson. Med. 2004, 52:1302-1309.
91. McDannold N., Fossheim S.L., Rasmussen H., Martin H., Natalia Vykhodtseva N., Hynynen K. Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. Radiology 2004, 230:743-752.
92. Peller M., Schwerdt A., Hossann M., Reinl H.M., Wang T., Sourbron S., Ogris M., Lindner L.H. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors. Invest. Radiol. 2008, 43:877-892.
93. Salomir R., Palussiere J., Fossheim S.L., Rogstad A., Wiggen U.N., Grenier N., Moonen C.T. Local delivery of magnetic resonance (MR) contrast agent in kidney using thermosensitive liposomes and MR imaging-guided local hyperthermia: a feasibility study in vivo. J. Magn. Reson. Imaging 2005, 22:534-540.
94. Viglianti B.L., Abraham S.A., Michelich C.R., Yarmolenko P.S., MacFall J.R., Bally M.B., Dewhirst M.W. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn. Reson. Med. 2004, 51:1153-1162.
95. Viglianti B.L., Ponce A.M., Michelich C.R., Yu D., Abraham S.A., Sanders L., Yarmolenko P.S., Schroeder T., MacFall J.R., Barboriak D.P., Colvin O.M., Bally M.B., Dewhirst M.W. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn. Reson. Med. 2006, 56:1011-1018.
96. Ponce A.M., Viglianti B.L., Yu D., Yarmolenko P.S., Michelich C.R., Woo J., Bally M.B., Dewhirst M.W. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J. Natl Cancer Inst. 2007, 99:53-63.
97. de Smet M., Langereis S., van den Bosch S., Grull H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J. Control. Release 2010, 143:120-127.
98. Langereis S., Keupp J., van Velthoven J.L., de Roos I.H., Burdinski D., Pikkemaat J.A., Grull H. A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery. J. Am. Chem. Soc. 2009, 131:1380-1381.
99. Frulio N., Trillaud H., Deckers R., Lepreux S., Moonen C., Quesson B. Influence of ultrasound induced cavitation on magnetic resonance imaging contrast in the rat liver in the presence of macromolecular contrast agent. Invest. Radiol. 2010, 45:282-287.
100. Parker D.L., Smith V., Sheldon P., Crooks L.E., Fussell L. Temperature distribution measurements in two-dimensional NMR imaging. Med. Phys. 1983, 10:321-325.
101. De Poorter J., De Wagter C., De Deene Y., Thomsen C., Stahlberg F., Achten E. Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: in vivo results in human muscle. Magn. Reson. Med. 1995, 33:74-81.
102. Ishihara Y., Calderon A., Watanabe H., Okamoto K., Suzuki Y., Kuroda K. A precise and fast temperature mapping using water proton chemical shift. Magn. Reson. Med. 1995, 34:814-823.
103. Denis de Senneville B., Quesson B., Moonen C.T. Magnetic resonance temperature imaging. Int. J. Hyperthermia 2005, 21:515-531.
104. Mougenot C., Quesson B., de Senneville B.D., de Oliveira P.L., Sprinkhuizen S., Palussiere J., Grenier N., Moonen C.T. Three-dimensional spatial and temporal temperature control with MR thermometry-guided focused ultrasound (MRgHIFU). Magn. Reson. Med. 2009, 61:603-614.
105. Bos C., Lepetit-Coiffe M., Quesson B., Moonen C.T. Simultaneous monitoring of temperature and T1: methods and preliminary results of application to drug delivery using thermosensitive liposomes. Magn. Reson. Med. 2005, 54:1020-1024.
106. Rudin M. Noninvasive structural, functional, and molecular imaging in drug development. Curr. Opin. Chem. Biol. 2009, 13:360-371.
107. Ferrara K., Pollard R., Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu. Rev. Biomed. Eng. 2007, 9:415-447.
108. Lentacker I., De Smedt S.C., Sanders N.N. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 2009, 5:2161-2170.
109. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
110. Brown E.B., Campbell R.B., Tsuzuki Y., Xu L., Carmeliet P., Fukumura D., Jain R.K. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat. Med. 2001, 7:864-868.
111. Kim J.B., Leucht P., Morrell N.T., Schwettman H.A., Helms J.A. Visualizing in vivo liposomal drug delivery in real-time. J. Drug Target. 2007, 15:632-639.
112. Li L., ten Hagen T.L., Schipper D., Wijnberg T.M., van Rhoon G.C., Eggermont A.M., Lindner L.H., Koning G.A. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J. Control. Release 2010, 143:274-279.
113. Kheirolomoom A., Kruse D.E., Qin S., Watson K.E., Lai C.Y., Young L.J., Cardiff R.D., Ferrara K.W. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J. Control. Release 2010, 141:128-136.
114. Paoli E.E., Kruse D.E., Seo J.W., Zhang H., Kheirolomoom A., Watson K.D., Chiu P., Stahlberg H., Ferrara K.W. An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation. J. Control. Release 2010, 143:13-22.
115. Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P.W., Langer R., Farokhzad O.C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett. 2007, 7:3065-3070.
116. Ntziachristos V., Ripoll J., Wang L.V., Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 2005, 23:313-320.
117. Palmer G.M., Boruta R.J., Viglianti B.L., Lan L., Spasojevic I., Dewhirst M.W. Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy. J. Control. Release 2010, 142:457-464.